Drug Store News - Merck - Reporter’s Notebook: Branded News - approval gained for Singulair for hay fever relief in adults and children - Brief Article
Wednesday, September 10th, 2008 The FDA also approved this month Merck’s Singulair for the relief of symptoms of hay fever in adults and children as young as 2 years of age.
Unlike antihistamines, Singulair treats seasonal allergies by blocking leukotrienes, substances produced by certain cells in the human …
